Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 116
Filtrar
1.
Clin Genet ; 93(2): 301-309, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28708278

RESUMO

The inherited peripheral neuropathies (IPNs) are characterized by marked clinical and genetic heterogeneity and include relatively frequent presentations such as Charcot-Marie-Tooth disease and hereditary motor neuropathy, as well as more rare conditions where peripheral neuropathy is associated with additional features. There are over 250 genes known to cause IPN-related disorders but it is estimated that in approximately 50% of affected individuals a molecular diagnosis is not achieved. In this study, we examine the diagnostic utility of whole-exome sequencing (WES) in a cohort of 50 families with 1 or more affected individuals with a molecularly undiagnosed IPN with or without additional features. Pathogenic or likely pathogenic variants in genes known to cause IPN were identified in 24% (12/50) of the families. A further 22% (11/50) of families carried sequence variants in IPN genes in which the significance remains unclear. An additional 12% (6/50) of families had variants in novel IPN candidate genes, 3 of which have been published thus far as novel discoveries (KIF1A, TBCK, and MCM3AP). This study highlights the use of WES in the molecular diagnostic approach of highly heterogeneous disorders, such as IPNs, places it in context of other published neuropathy cohorts, while further highlighting associated benefits for discovery.


Assuntos
Doença de Charcot-Marie-Tooth/genética , Sequenciamento do Exoma , Sequenciamento de Nucleotídeos em Larga Escala , Doenças do Sistema Nervoso Periférico/genética , Acetiltransferases/genética , Doença de Charcot-Marie-Tooth/diagnóstico , Doença de Charcot-Marie-Tooth/patologia , Exoma/genética , Feminino , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/genética , Cinesinas/genética , Masculino , Mutação , Doenças do Sistema Nervoso Periférico/diagnóstico , Doenças do Sistema Nervoso Periférico/patologia , Proteínas Serina-Treonina Quinases/genética
2.
J Nurs Manag ; 23(8): 974-82, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25131319

RESUMO

AIM: This study aimed to establish and describe the level of communication satisfaction that professional nurses experience in selected public hospitals in the City of Johannesburg, South Africa. BACKGROUND: The success of any organisation depends on the effectiveness of its communication systems and the interaction between staff members. METHOD: Data were collected by means of questionnaires, based on the Communication Satisfaction Questionnaire (CSQ), from a sample of 265 professional nurses from different categories, chosen using a disproportionate random stratified sampling method. RESULTS: The results indicated poor personal feedback between nurse managers (operational managers) and professional nurses, as well as dissatisfaction among nurse managers and professional nurses with regard to informal communication channels. A lack of information pertaining to policies, change, financial standing and achievements of hospitals was identified. CONCLUSION: Nurse managers should play a leadership role in bringing staff of different departments together by creating interactive communication forums for the sharing of ideas. IMPLICATIONS FOR NURSING MANAGEMENT: The results emphasise the need for nurse managers to improve communication satisfaction at all levels of the hospital services in order to enhance staff satisfaction and create a positive working environment for staff members.


Assuntos
Atitude do Pessoal de Saúde , Comunicação , Hospitais Públicos/organização & administração , Recursos Humanos de Enfermagem Hospitalar/psicologia , Local de Trabalho/psicologia , Adulto , Feminino , Humanos , Satisfação no Emprego , Liderança , Masculino , Pessoa de Meia-Idade , Enfermeiros Administradores/psicologia , Satisfação Pessoal , África do Sul
3.
Vet Pathol ; 47(4): 713-8, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20460450

RESUMO

Diabetes mellitus (DM) is a group of chronic metabolic diseases characterized by persistent fasting hyperglycemia, and it can be of either polygenic or monogenic origin. Animal models have played an important role in elucidating the pathophysiology of the polygenic Type 1 and type 2 DM forms; however, useful animal models of the monogenic forms do not exist. The authors describe 4 cases of naturally occurring DM in vervet monkeys (Chlorocebus aethiops sabaeus), 1 of which has clinicopathologic findings consistent with type 2 DM, including persistent hyperglycemia, hypertriglyceridemia, islet amyloidosis, and reduced islet insulin immunostaining. In contrast, the 3 remaining animals have clinicopathologic similarities to a monogenic form of the disease, including a lack of islet amyloidosis and hypertriglyceridemia, as well as normal islet insulin immunostaining. In addition, pedigree analysis conducted on one of these animals is consistent with either an autosomal dominant or mitochondrial inheritance pattern, which supports a monogenic form of DM. The authors thus hypothesize that a naturally occurring monogenic form of diabetes may occur in vervet monkeys, making them a potential animal model for future studies.


Assuntos
Glicemia/metabolismo , Diabetes Mellitus Tipo 2/veterinária , Insulina/metabolismo , Ilhotas Pancreáticas/metabolismo , Doenças dos Macacos/metabolismo , Amiloidose/metabolismo , Animais , Glicemia/análise , Chlorocebus aethiops , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/metabolismo , Feminino , Imuno-Histoquímica/veterinária , Insulina/sangue , Masculino , Doenças dos Macacos/genética , Linhagem , Triglicerídeos/sangue
4.
Diabetologia ; 53(1): 111-4, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19847395

RESUMO

AIMS/HYPOTHESIS: We sought to establish the relationship between fasting plasma glucose concentrations and pancreatic fractional beta cell area in adult cynomolgus monkeys (Macaca fascicularis). METHODS: Fasting plasma glucose and pancreatic fractional beta cell area were measured in 18 control and 17 streptozotocin-treated adult primates (17.0 +/- 1.2 vs 15.4 +/- 1.2 years old). RESULTS: Fasting plasma glucose was increased (12.0 +/- 2.0 vs 3.4 +/- 0.1 mmol/l, p < 0.01) and fractional beta cell area was decreased (0.62 +/- 0.13% vs 2.49 +/- 0.35%, p < 0.01) in streptozotocin-treated monkeys. The relationship between fasting plasma glucose and pancreatic fractional beta cell area was described by a wide range of beta cell areas in controls. In streptozotocin-treated monkeys there was an inflection of fasting blood glucose at approximately 50% of the mean beta cell area in controls with a steep increase in blood glucose for each further decrement in beta cell area. CONCLUSIONS/INTERPRETATION: In adult non-human primates a decrement in fractional beta cell area of approximately 50% or more leads to loss of glycaemic control.


Assuntos
Glicemia/metabolismo , Hiperglicemia/sangue , Células Secretoras de Insulina/patologia , Animais , Diabetes Mellitus Experimental/patologia , Jejum , Humanos , Hiperglicemia/patologia , Células Secretoras de Insulina/citologia , Células Secretoras de Insulina/fisiologia , Macaca fascicularis , Masculino
5.
Arch Pediatr ; 13(9): 1236-8, 2006 Sep.
Artigo em Francês | MEDLINE | ID: mdl-16824740

RESUMO

A sigmoid tuberculosis is very rare. We report a case of sigmoid pseudotumoral tuberculosis with a fistulization into the urinary bladder in a 10-year-old girl. The diagnosis of tuberculosis was made by histopathological examination of the surgical specimen after segmental colectomy. Surgery completed by antitubercular chemotherapy gave a good result.


Assuntos
Fístula Intestinal/microbiologia , Doenças do Colo Sigmoide/diagnóstico , Tuberculose Gastrointestinal/diagnóstico , Fístula Urinária/microbiologia , Criança , Feminino , Humanos
7.
Science ; 300(5627): 1875, 2003 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-12817123
8.
Nucl Med Commun ; 24(3): 281-9, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12612469

RESUMO

One hundred and nineteen patients with malignant melanoma were studied using 2-[ F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET). The images were reconstructed using ordered subset expectation maximization with and without attenuation correction and filtered backprojection with and without attenuation correction. The most probable draining lymph node chains were surgically explored and the tumour volume was quantified at histology. The four different reconstructions of the PET images were retrospectively graded on a five-point scale by two blind readers and compared with the tumour volume. The readers agreed within +/-1 grade 93% (529/568) of the time. Comparing the areas under the receiver operating characteristic (ROC) curves gave 0.698, 0.668, 0.694 and 0.684 for the four reconstruction techniques. The lowest value comparing any pair of the four reconstruction techniques was P=0.371. Thus, none of the reconstruction techniques gave significantly better results than any of the others. The sensitivity of detection was 85% for tumour volumes of 113 m or more (about 6 mm in diameter), but only 4% for tumours less than this size. It can be concluded that the use of attenuation correction gives aesthetically more pleasing images, but the sensitivity and specificity are not significantly improved.


Assuntos
Fluordesoxiglucose F18 , Processamento de Imagem Assistida por Computador/métodos , Melanoma/diagnóstico por imagem , Neoplasias Cutâneas/diagnóstico por imagem , Tomografia Computadorizada de Emissão/métodos , Adulto , Idoso , Feminino , Humanos , Linfonodos/diagnóstico por imagem , Metástase Linfática , Masculino , Melanoma/patologia , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Compostos Radiofarmacêuticos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Biópsia de Linfonodo Sentinela , Neoplasias Cutâneas/patologia
9.
Cell Death Differ ; 9(8): 856-61, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12107828

RESUMO

To identify genes that contribute to apoptotic resistance, IL-3 dependent hematopoietic cells were transfected with a cDNA expression library and subjected to growth factor withdrawal. Transfected cells were enriched for survivors over two successive rounds of IL-3 withdrawal and reconstitution, resulting in the identification of a full-length elongation factor 1 alpha (EF-1alpha) cDNA. Ectopic EF-1alpha expression conferred protection from growth factor withdrawal and agents that induce endoplasmic reticulum stress, but not from nuclear damage or death receptor signaling. Overexpression of EF-1alpha did not lead to growth factor independent cell proliferation or global alterations in protein levels or rates of synthesis. These findings suggest that overexpression of EF-1alpha results in selective resistance to apoptosis induced by growth factor withdrawal and ER stress.


Assuntos
Apoptose/genética , Retículo Endoplasmático/metabolismo , Células Eucarióticas/metabolismo , Interleucina-3/deficiência , Fator 1 de Elongação de Peptídeos/metabolismo , Estresse Fisiológico/metabolismo , Animais , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/genética , Divisão Celular/efeitos dos fármacos , Divisão Celular/genética , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/genética , Células Cultivadas , Relação Dose-Resposta a Droga , Retículo Endoplasmático/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Células Eucarióticas/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Humanos , Interleucina-3/farmacologia , Fator 1 de Elongação de Peptídeos/genética , Inibidores da Síntese de Proteínas/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/genética , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Estresse Fisiológico/genética , Proteína bcl-X
10.
Clin Nephrol ; 57(3): 221-9, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11924754

RESUMO

Lymphopenia is a common finding in dialysis patients. Since infection rate and mortality associated with infection are high in dialysis patients, lymphopenia may be one of the contributing factors. In the present study, we evaluated the mechanism responsible for lymphopenia in these patients. Lymphocytes isolated from dialysis patients showed increased apoptosis (p < 0.001) when compared to lymphocytes isolated from healthy subjects (healthy subjects, 0.5 +/- 0.2% vs. dialysis patients, 8.8 +/- 0.7% apoptotic cells/field). Sera from dialysis patients promoted lymphocyte apoptosis in a time- and dose-dependent manner. These sera also enhanced lymphocyte DNA fragmentation into multiple integers of 180 base pairs in the form of a ladder pattern. Cellulose acetate membranes promoted T cell apoptosis when compared to polysulfone membranes and to control. Cellulose acetate dialysis membranes also appear to promote lymphocyte FasL expression. Similarly, dialysis sera enhanced T cell Fas as well as FasL expression. Neither the cellulose acetate nor polysulfone membranes could induce FasL expression on B cells. Similarly, dialysis sera failed to induce FasL expression on B cells. On the other hand, anti-FasL antibodies attenuated dialysis sera-induced apoptosis in T as well as B cells. Interestingly, dialysis serum showed a 5-fold increase in FasL content when compared with control serum. These results suggest that dialysis-associated factors can induce autocrine death in T cells but the help of activated T cells is required to induce death in B cells.


Assuntos
Apoptose/fisiologia , Linfócitos/fisiologia , Linfopenia/etiologia , Glicoproteínas de Membrana/metabolismo , Diálise Renal/efeitos adversos , Adulto , Idoso , Anticorpos Anti-Idiotípicos/fisiologia , Sangue , Linhagem Celular , Fragmentação do DNA , Proteína Ligante Fas , Feminino , Humanos , Linfopenia/fisiopatologia , Masculino , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/imunologia , Pessoa de Meia-Idade , Linfócitos T/fisiologia , Receptor fas/metabolismo
11.
Clin Nephrol ; 58(6): 423-30, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12508964

RESUMO

BACKGROUND: The mononuclear phagocyte system plays an important role in host defense. Since dialysis patients have been reported to show enhanced leukocytes apoptosis, we evaluated the mechanism of increased apoptosis of monocytes in dialysis patients. METHODS: Apoptotic studies were carried out on monocytes isolated from dialysis patients as well as healthy subjects. The effect of dialysis sera and membranes was evaluated on monocyte apoptosis as well as monocyte expression of proapoptotic proteins such as Fas and FasL. To confirm the role of FasL, we evaluated the effect of activated secretory products on T cell apoptosis. In addition, we studied FasL content of dialysis sera and supernatants of activated monocytes. RESULTS: Monocytes isolated from dialysis patients (MDP) showed a greater magnitude of apoptosis when compared to monocytes isolated from healthy subjects (MHS) (MHS, 3.6 +/- 1.1% vs. MDP, 24.3 +/-1.4%). Sera of hemodialysis patients (SHD) promoted (p < 0.001) apoptosis of MHS when compared to pooled control sera (HPS) (HPS, 0.8 +/- 0.5% vs. SHD, 11.5 +/- 0.5% apoptotic cells/field). Dialysis membranes, cellulose acetate membranes in particular, promoted monocyte apoptosis. Interestingly, anti-FasL antibodies partly inhibited dialysis sera-induced monocyte apoptosis. Dialysis membranes also modulated monocyte expression of both Fas and FasL. Secretory products of activated monocytes also promoted T cell apoptosis. Dialysis sera and activated monocyte secretory products showed increased FasL content. CONCLUSIONS: These results suggest that dialysis patients have an increased rate of monocyte apoptosis, which is mediated through a uremic milieu (serum factors). One of these serum factors seems to be FasL. In addition, dialysis membranes seem to promote apoptosis independent of the uremic milieu. The present study provides a mechanistical insight into the enhanced apoptosis of monocytes in dialysis patients.


Assuntos
Apoptose , Glicoproteínas de Membrana/fisiologia , Monócitos , Diálise Renal , Western Blotting , Ensaio de Imunoadsorção Enzimática , Proteína Ligante Fas , Feminino , Humanos , Masculino , Membranas Artificiais , Pessoa de Meia-Idade
12.
J Clin Endocrinol Metab ; 86(11): 5396-404, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11701713

RESUMO

This study compared the effects of tibolone, a tissue-specific compound for the treatment of climacteric symptoms and the prevention of osteoporosis, with those of conjugated equine estrogens (CEE) with and without medroxyprogesterone (MPA) on bone mineral density and coronary atherosclerosis (CAA) of postmenopausal cynomolgus monkeys. The groups were tibolone [two doses were used, 0.05 mg/kg (LoTib) and 0.2 mg/kg (HiTib)], CEE (0.042 mg/kg), CEE (0.042 mg/kg) plus MPA (0.167 mg/kg given continuously), and a control group given no treatment for 2 yr. Compared with no treatment, bone mineral density was higher by 6.3% (P = 0.0004) in the LoTib group and by 9.5% (P = 0.02) in the HiTib group compared with 4.3% (P = 0.12) for CEE and 4.5% (P = 0.10) for CEE+MPA. Plasma high density lipoprotein cholesterol was reduced by 49% with HiTib and by 34% with LoTib. There were no differences in CAA between control and HiTib (P = 0.60) or LoTib (P = 0.58). CEE and CEE+MPA both reduced CAA by about 62% (CEE vs. control, P = 0.02; CEE+MPA vs. control, P = 0.01). Despite adverse effects of tibolone on plasma lipoprotein concentrations, there was no increase in CAA, suggesting that tibolone is a cardiovascular-safe treatment for climacteric symptoms and the prevention of osteoporosis.


Assuntos
Antineoplásicos Hormonais/farmacologia , Arteriosclerose/tratamento farmacológico , Densidade Óssea/efeitos dos fármacos , Doença das Coronárias/tratamento farmacológico , Estrogênios/farmacologia , Norpregnenos/farmacologia , Pós-Menopausa/fisiologia , Animais , Antineoplásicos Hormonais/sangue , Apolipoproteínas/sangue , Arteriosclerose/patologia , Peso Corporal/efeitos dos fármacos , HDL-Colesterol/sangue , Doença das Coronárias/patologia , Estradiol/farmacologia , Estrogênios/sangue , Estrona/farmacologia , Feminino , Cavalos , Lipoproteínas/sangue , Macaca fascicularis , Medroxiprogesterona/farmacologia , Norpregnenos/sangue , Congêneres da Progesterona/farmacologia
14.
Clin Nephrol ; 56(1): 52-9, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11499659

RESUMO

Patients on hemodialysis are prone to infection. Neutrophils are the host's first line of defense against certain invading pathogenic microorganisms. Since apoptotic neutrophils are functionally compromised we examined the effect of dialysis membranes on neutrophil apoptosis. Dialysis patients showed greater (p < 0.001) neutrophil apoptosis when compared with control subjects. Cellulose acetate membranes directly promoted (p < 0.001) neutrophil apoptosis. Cellulose acetate membrane-treated neutrophils exhibited greater apoptosis (p < 0.01) when compared with polysulfone membrane-treated neutrophils. Superoxide dismutase (SOD) partly inhibited the cellulose acetate membrane-induced neutrophil apoptosis, whereas both catalase and dimethylthiourea (DMTU) inhibited the polysulfone membrane-induced neutrophil apoptosis. Similarly, L-NAME, a nitric oxide synthase inhibitor, attenuated both the cellulose acetate and the polysulfone membrane-induced neutrophil apoptosis. In addition, cellulose acetate and monocyte interaction products promoted (p < 0.001) neutrophil apoptosis. These results suggest that dialysis membranes can promote neutrophil apoptosis directly as well as through their interaction with monocytes. The direct effect of dialysis membranes seems to be mediated partly through the generation of reactive oxygen species.


Assuntos
Apoptose , Celulose/análogos & derivados , Radicais Livres/farmacologia , Membranas Artificiais , Neutrófilos/patologia , Análise de Variância , Estudos de Casos e Controles , Celulose/efeitos adversos , Fragmentação do DNA , Relação Dose-Resposta a Droga , Eletroforese em Gel de Ágar , Feminino , Humanos , Falência Renal Crônica/sangue , Falência Renal Crônica/terapia , Masculino , Necrose , Polímeros/efeitos adversos , Diálise Renal/instrumentação , Sulfonas/efeitos adversos
15.
Am J Obstet Gynecol ; 185(2 Suppl): S24-31, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11521119

RESUMO

Progestins used in oral contraceptive formulations available in the United States include norgestimate, desogestrel, norethindrone, norethindrone acetate, and levonorgestrel. Progestins used in the United States in continuous and intermittent formulations of hormone replacement therapy are norgestimate, medroxyprogesterone acetate, and norethindrone acetate. The chemical structure of a progestin determines its relative binding affinity for the progesterone and androgen receptors, as well as the sex hormone binding globulin in human serum, and determines its clinical profile. Overall, the properties of levonorgestrel or norethindrone acetate in this regard differ from norgestimate and are more conducive to androgenic stimulation. Estrogen replacement offers cardioprotective effects in postmenopausal women. Progestins are added to hormone replacement therapy to counteract the well-known increased risk of endometrial hyperplasia associated with the use of unopposed estrogen. Animal models show that for some parameters, including improvement of lipid profiles, progestins can diminish the cardioprotective effect of estrogen. Initial animal studies of norgestimate combined with estrogen do not show an attenuation of estrogenic effects.


Assuntos
Anticoncepcionais Orais Combinados , Terapia de Reposição Hormonal , Progestinas/administração & dosagem , Progestinas/farmacocinética , Animais , Doenças Cardiovasculares/prevenção & controle , Química Farmacêutica , Modelos Animais de Doenças , Hiperplasia Endometrial/prevenção & controle , Feminino , Humanos , Progestinas/química
16.
J Surg Oncol ; 77(4): 237-42, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11473371

RESUMO

BACKGROUND AND OBJECTIVES: The purpose of this study is to determine the tumor volume threshold for successful positron emission tomography (PET) imaging of melanoma nodal metastases. METHODS: Review of a clinical series of patients who had FDG-PET imaging of regional lymph node basins followed by lymphadenectomy. Lymph node tumor volumes were calculated from direct measurements of metastatic nodule(s) in formalin fixed specimens. PET scan interpretations were correlated with histology to determine sensitivity. Sensitivity was correlated with the aggregate lymph node tumor volume in the nodal basin and with AJCC stage group. RESULTS: Forty-five patients with 49 pathologically positive regional nodal basins comprised the study group. Median total basin tumor volume was 28.3 mm(3)(range 0.004-22,879 mm(3)). FDG-PET sensitivity for detection of all tumor volumes was 0.49. The observed 90% sensitivity threshold for detection of nodal metastases was > or = 78 mm(3). PET sensitivity was 0.14 for detection of tumor volumes < 78 mm(3). PET sensitivity differed by prescan AJCC stage: I-0.0; II-0.24; III-0.81; IV-1.0 (P < 0.001). CONCLUSIONS: FDG-PET reliably detects lymph node tumor deposits greater than approximately 80 mm(3) volume, but sensitivity falls rapidly below this. This amount of tumor is most likely to occur in patients with AJCC stage III or IV disease.


Assuntos
Fluordesoxiglucose F18 , Metástase Linfática/diagnóstico por imagem , Melanoma/diagnóstico por imagem , Melanoma/patologia , Compostos Radiofarmacêuticos , Tomografia Computadorizada de Emissão , Excisão de Linfonodo , Linfonodos/patologia , Metástase Linfática/patologia , Radiografia , Estudos Retrospectivos , Sensibilidade e Especificidade
17.
J Clin Invest ; 107(7): 853-60, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11285304

RESUMO

Recent evidence argues strongly that the marked increase in risk for atherosclerotic heart disease seen in diabetics cannot be explained by a generalized increase in oxidative stress. Here, we used streptozotocin to induce hyperglycemia in cynomolgus monkeys for 6 months and tested whether high glucose levels promote localized oxidative damage to artery wall proteins. We focused on three potential agents of oxidative damage: hydroxyl radical, tyrosyl radical, and reactive nitrogen species. To determine which pathways operate in vivo, we quantified four stable end products of these reactants -- ortho-tyrosine, meta-tyrosine, o,o'-dityrosine, and 3-nitrotyrosine -- in aortic proteins. Levels of ortho-tyrosine, meta-tyrosine, and o,o'-dityrosine, but not of 3-nitrotyrosine, were significantly higher in aortic tissue of hyperglycemic animals. Of the oxidative agents we tested, only hydroxyl radical mimicked this pattern of oxidized amino acids. Moreover, tissue levels of ortho-tyrosine and meta-tyrosine correlated strongly with serum levels of glycated hemoglobin, a measure of glycemic control. We conclude that short-term hyperglycemia in primates promotes oxidation of artery wall proteins by a species that resembles hydroxyl radical. Our observations suggest that glycoxidation reactions in the arterial microenvironment contribute to early diabetic vascular disease, raising the possibility that antioxidant therapies might interrupt this process.


Assuntos
Aorta/metabolismo , Arteriosclerose/metabolismo , Diabetes Mellitus Experimental/metabolismo , Radical Hidroxila/metabolismo , Tirosina/análogos & derivados , Animais , Arteriosclerose/etiologia , Arteriosclerose/patologia , Glucose/metabolismo , Hemoglobinas Glicadas/análise , Lipídeos/sangue , Macaca fascicularis , Masculino , Espectrometria de Massas/métodos , Oxirredução , Fatores de Tempo , Tirosina/metabolismo
18.
Toxicol Pathol ; 29(1): 142-8, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11215678

RESUMO

Diabetes is a major health problem of increasing incidence in the United States. Diabetes research has been limited by lack of availability of good animal models, particularly for the study of comorbidities associated with diabetes. We investigated the use of cynomolgus monkeys as an animal model of both type 1 and type 2 diabetes and compared these naturally occurring diseases with streptozotocin-induced diabetes. Both type 1 diabetics and streptozotocin-induced diabetics present with sudden onset of hyperglycemia and are ketosis prone without exogenous insulin. Type 2 diabetics can have a very long period of moderate hyperglycemia and hypertriglyceridemia and only require exogenous insulin therapy if pancreatic islet reserves are depleted. Type 2 diabetes is preceded by a relatively long period of insulin resistance that is associated with obesity and dyslipidemia. As insulin resistance progresses, islet size and insulin content increases initially. However, with sustained periods of insulin resistance, islet amyloid polypeptide (IAPP) is deposited in islets and can replace normal islet architecture, resulting in an insulin-deficient state. Appearance of IAPP also occurs in human type 2 diabetics but not in conventional rodent models. Unlike type 2 diabetes, neither type 1 nor streptozotocin-induced diabetes is associated with IAPP. Rather, islets can appear normal histologically, but have decreased insulin secretion and immunostaining. Further, the amount of insulin present in the islet is correlated with plasma insulin levels following glucose challenge. Studies are ongoing to determine the pathogenic changes associated with the progression of diabetes and to find novel drug treatments for diabetics.


Assuntos
Metabolismo dos Carboidratos , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patologia , Diabetes Mellitus/metabolismo , Diabetes Mellitus/patologia , Ilhotas Pancreáticas/metabolismo , Ilhotas Pancreáticas/patologia , Metabolismo dos Lipídeos , Animais , Dieta Aterogênica , Progressão da Doença , Feminino , Teste de Tolerância a Glucose , Insulina/sangue , Lipídeos/sangue , Lipoproteínas/sangue , Macaca fascicularis , Masculino
19.
Metabolism ; 49(9): 1188-96, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11016902

RESUMO

We have previously shown that soy protein consumption improves lipoprotein concentrations and reduces the progression of atherosclerosis in cynomolgus monkeys. The mechanism for these beneficial effects is unclear. The purpose of this study was to determine potential mechanisms for the atheroprotective effects of soy and to determine if these effects extend to diabetic monkeys. We designed an experiment with a 2 x 2 factorial design in which adult male monkeys (N = 23) were fed an atherogenic diet with a protein source of either soy isolate or casein and lactalbumin, and the monkeys were either control or streptozotocin-induced diabetic. Diabetics had significantly increased fasting glucose and glycated hemoglobin (GHb) levels; this relationship was not affected by the type of dietary protein. Diabetics also had increased total (TC) and low-density lipoprotein cholesterol (LDLC) concentrations. However, soy consumption significantly reduced TC and LDLC concentrations in both control and diabetic monkeys. Plasma and arterial LDL metabolism was determined by injecting 125I-LDL at 48 hours and 131I-tyramine cellobiose LDL at 1 hour prior to necropsy. This allowed a determination of the arterial LDL concentration, permeability, and arterial LDL delivery. An increase in the whole-body plasma LDL fractional catabolic rate (FCR) was found with soy. Soy significantly reduced the arterial LDL concentration across all arterial sites by an average of 50%. Soy also significantly reduced the delivery of LDLC to all arterial sites by an average of 40%. While this was primarily due to the lower plasma LDLC concentration, LDL permeability in the carotid bifurcation and internal carotid arteries was also reduced. There was no additional effect of diabetes. These beneficial effects on plasma and arterial LDL metabolism would be expected to reduce atherosclerosis and were found in both control and diabetic monkeys.


Assuntos
LDL-Colesterol/sangue , Proteínas Alimentares/farmacologia , Lipoproteínas LDL/sangue , Proteínas de Soja/farmacologia , Animais , Aorta Abdominal/química , Aorta Abdominal/metabolismo , Artérias/química , Artérias/metabolismo , Artérias Carótidas/química , Artérias Carótidas/metabolismo , HDL-Colesterol/sangue , LDL-Colesterol/análise , Vasos Coronários/química , Vasos Coronários/metabolismo , Proteínas Alimentares/administração & dosagem , Macaca fascicularis , Masculino , Permeabilidade , Proteínas de Soja/administração & dosagem
20.
Cancer ; 89(2): 453-62, 2000 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-10918179

RESUMO

BACKGROUND: The selection of patients for sentinel lymph node biopsy (SNB) and selective lymphadenectomy for histologically positive sentinel lymph nodes (SLND) are areas of debate. The authors of the current study attempted to identify predictors of metastases to the sentinel and residual nonsentinel lymph nodes in patients with melanoma. METHODS: The Indiana University Interdisciplinary Melanoma Program computerized database was queried to identify all patients who underwent SNB for clinically localized cutaneous melanoma. Demographic, surgical, and histopathologic data were recorded. Univariate and multivariate logistic regression analyses were performed to identify associations with SNB and nonsentinel lymph node positivity. Classification tree and logistic procedures were performed to identify the ideal tumor thickness cutpoint at which to perform SNB. RESULTS: Two hundred seventy-five SNB procedures were performed to stage 348 regional lymph node basins for occult metastases from melanoma. Of the 275 melanomas, 54 (19.6%) had a positive SNB, as did 58 of 348 basins (16.7%). Classification and logistic regression analysis identified a Breslow depth of 1.25 mm to be the most significant cutpoint for SNB positivity (odds ratio 8. 8:1; P = 0.0001). By multivariate analyses, a Breslow thickness cutpoint >/= 1.25 mm (P = 0.0002), ulceration (P = 0.005), and high mitotic index (> 5 mitoses/high-power field; P = 0.04) were significant predictors of SNB results. SLND was performed in 53 SNB positive patients, 15 of whom (28.3%) had at least 1 additional positive lymph node. SLND positivity was noted across a wide range of primary tumor characteristics and was associated significantly with multiple positive SN, but not with any other variable. SNB result correlated significantly with disease free and overall survival. CONCLUSIONS: Patients with a Breslow tumor thickness >/= 1. 25 mm, ulceration, and high mitotic index are most likely to have positive SNB results. SLND is recommended for all patients after positive SNB because it is difficult to identify patients with residual lymph node disease.


Assuntos
Biópsia/métodos , Linfonodos/patologia , Melanoma/patologia , Melanoma/secundário , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/secundário , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Modelos Logísticos , Excisão de Linfonodo , Linfonodos/cirurgia , Metástase Linfática , Masculino , Melanoma/cirurgia , Pessoa de Meia-Idade , Análise Multivariada , Valor Preditivo dos Testes , Neoplasias Cutâneas/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA